文献速递运动医学关节外科创伤骨科

肩关节镜术后皮质类固醇注射时机影响术后感染风险

The Timing of Corticosteroid Injections After Arthroscopic Shoulder Procedures Affects Postoperative Infection Risk.
PubMed 文献 · Am J Sports Med · 2019-02-13

基于美国商业保险与联邦医疗保险数据库的队列研究(证据等级3)纳入3946例肩关节镜术后患者,比较术后1、2、3、4个月内接受皮质类固醇注射者与匹配对照组的90天感染率。术后1个月内注射者感染率显著高于对照(商业保险OR 2.63,P=0.014;联邦医疗保险OR 11.2,P<0.0001),其余时间点无差异。作者提示术后即刻期注射需谨慎。

要点

  • 术后1个月内关节内皮质类固醇注射与感染率升高相关(商业保险OR 2.63,联邦医疗保险OR 11.2)。
  • 术后2、3、4个月注射者感染率与未注射对照组无显著差异(P=0.264-0.835)。
  • 作者基于数据库关联性结果提示术后即刻期注射皮质类固醇需谨慎,但无法确定因果关系。

核心结论

  • 研究结果支持在肩关节镜术后即刻期给予皮质类固醇注射时需谨慎。
  • 作者发现术后1个月接受关节内皮质类固醇注射与术后感染率升高存在显著关联,但基于该数据库回顾无法确定因果关系。

研究设计与样本

  • 队列研究,证据等级3。
  • 查询全国商业保险与联邦医疗保险数据库,纳入接受关节镜下肩袖修复、清创或肩峰下减压的患者。
  • 识别术后1、2、3或4个月内接受皮质类固醇注射的患者,并与接受相同手术但未行术后类固醇注射的匹配对照组比较。
  • 使用《国际疾病分类》第九版和《现行操作术语》编码识别注射后90天内的术后感染率。
  • 采用多因素二项逻辑回归分析比较组间差异,计算校正比值比(OR)及95%CI,P<0.05为显著。

主要发现

  • 共识别3946例患者:术后1个月内注射264例,2个月内471例,3个月内1037例,4个月内1874例,匹配对照2640例。
  • 与对照组相比,术后1个月内注射者感染率显著更高(商业保险:OR 2.63,P=0.014;联邦医疗保险:OR 11.2,P<0.0001)。
  • 其余所有时间点的感染率均无差异(P=0.264-0.835)。

临床怎么用

  • 作者基于数据库关联性结果提示,肩关节镜术后即刻期给予皮质类固醇注射需谨慎。

局限性

  • 基于该数据库回顾无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticosteroid injections are sometimes used in the postoperative period after shoulder arthroscopy; however, a well-defined safety profile has not been established. PURPOSE: To examine the association between the timing of postoperative corticosteroid injections and rates of infection after shoulder arthroscopy. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Private payer and Medicare national insurance databases were queried for patients who underwent arthroscopic rotator cuff repair, debridement, or subacromial decompression. Patients who underwent corticosteroid injections within 1, 2, 3, or 4 months postoperatively were identified and compared with a matched control group that underwent the same procedures without a postoperative steroid injection. International Classification of Diseases, Ninth Revision, and Current Procedural Terminology codes were used to identify rates of postoperative infection within 90 days after injection for the study groups and controls. Multivariate binomial logistic regression analysis was used to compare groups, and adjusted odds ratios (ORs) and 95% CIs were calculated, with P < .05 considered significant. RESULTS: A total of 3946 patients were identified, including 264 patients who received an injection within 1 month after surgery, 471 within 2 months, 1037 within 3 months, 1874 within 4 months, and 2640 matched controls. When compared with controls, patients who underwent a corticosteroid injection within 1 month postoperatively had a significantly higher rate of infection (private payer: OR, 2.63; P = .014; Medicare: OR, 11.2; P < .0001). There were no differences in infection rates at all other time points ( P = .264-.835). CONCLUSION: This study adds to the evidence suggesting caution when administering injections in the immediate postoperative period after shoulder arthroscopy. Although causality cannot be determined on the basis of this database review, the authors found a significant association between intra-articular corticosteroid injections administered 1 month postoperatively and an increased rate of postoperative infection in Medicare and private payer patient cohorts as compared with a control group.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kew ME, Cancienne JM, Christensen JE, et al. The Timing of Corticosteroid Injections After Arthroscopic Shoulder Procedures Affects Postoperative Infection Risk. Am J Sports Med. 2019. PMID: 30758977. doi:10.1177/0363546518825348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。